Together, these results provide evidence that Arg1 activity promotes tumor growth and that elimination of myeloid cell Arg1 expression or pharmacological blockade of arginase by CB-1158 limits tumor growth in vivo. This evidence concerns the gene ARG1 and neoplasm.